Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation

The International Society of Vascularized Composite Allotransplantation (ISVCA) held its 13th congress "Defining Success" in October 2017 in Salzburg, Austria. A total of 122 delegates from 22 countries representing 5 continents attended the conference. The theme strived to provide pathways to accomplish best possible outcomes in this unique and multifaceted field of transplantation. 'Ignite talks', a new feature introduced for the first time at the Salzburg meeting served as key elements for productive discussions on both congress days. The "ignitors" had been selected as experts from Europe, the Americas and Asia in VCA and neighbouring disciplines and provided a global perspective of their topic. Posttransplant treatment regimens, including the most burdensome side effects of immunosuppressants in addition to novel and future therapeutic options were discussed in depth. An additional ethics symposium summarized and advanced topics that had been discussed during the first international workshop on bioethical challenges in reconstructive transplantation held earlier in 2017. Correspondence Annemarie Weissenbacher, MD, Oxford Transplant Centre, Nuffield Department of Surgical Sciences, University of Oxford, Old Road, Oxford, OX3 7LE, United Kingdom. Tel.: +447481147692. E-mail: annemarie.weissenbacher@nds.ox.ac.uk Authorship AW: local organising chair and chair of the SPC for the ISVCA congress, wrote the meeting report; LC, EM, PP, GB, PJF, VG, CK, JK, LSL, GV, SS: SPC members, participated in editing the meeting report Disclosure The authors declare no conflicts of interest. The authors have no funding to disclose. Funding No funding received. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

https://ift.tt/2uLTZiZ